The largest database of trusted experimental protocols

Ptre tight vector

Manufactured by Takara Bio
Sourced in United States

The PTRE-Tight vector is a plasmid used for gene expression in mammalian cell lines. It contains a tetracycline-responsive promoter that allows for tight regulation of target gene expression.

Automatically generated - may contain errors

20 protocols using ptre tight vector

1

Generation of AT-1 Transgenic Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
cDNA encoding human AT-1 was isolated by BamHI and EcoRV digestion from Topo-AT-1 constructs and subcloned into pTRE-Tight vector (Takara Bio Inc.). TRE-AT-1 Tg lines were generated by injection of linearized pTRE-Tight vector (Takara Bio Inc.) containing AT-1 cDNA into the pronucleus of fertilized eggs from FVB mice. Monogenic pTRE-AT-1 mice were backcrossed to WT C57BL/6 mice for five generations, and then bred to CamK2a-tTA mice (B6.Cg-Tg(Camk2a-tTA)1Mmay/DboJ; The Jackson Laboratory), generating nonTg WT, Camk2a-tTA monogenic, TRE-AT-1 monogenic, and CamK2a-tTA;TRE-AT-1 (referred to as AT-1 Tg) mice. Genotyping from tail DNA was performed using the following primers: AT-1 forward (5′-AATCTGGGAAACTGGCCTTCT-3′), AT-1 reverse (5′-TATTACCGCCTTTGAGTGAGCTGA-3′), Camk2a-tTA forward (5′-CGCTGTGGGGCATTTTACTTTAG-3′), and Camk2a-tTA reverse (5′-CATGTCCAGATCGAAATCGTC-3′).
Animal experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and were approved by the Institutional Animal Care and Use Committee of the University of Wisconsin-Madison and the Madison Veterans Administration Hospital. Unless specified, WT littermates were used as control throughout our study.
+ Open protocol
+ Expand
2

Generating Mutant HIF-1α Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hypoxia‐inducible factor 1α (NM_001530) was subcloned into the pTRE‐Tight vector (Clontech).19 For alanine (Ala) substitution of two proline (Pro) residues, Pro402 and Pro564, in HIF‐1α (P402A, P564A) in the pTRE‐Tight vector (HIF1αdPA), the QuikChange Site‐Directed Mutagenesis Kit (Stratagene, San Diego, CA, USA) was used according to the manufacturer's recommendations.19 To determine the importance of the oxygen‐dependent degradation (ODD) domain in HIF‐1α,22 HIF‐1α with amino acid 402‐603 deletion was inserted into the pTRE‐Tight vector (HIF1αΔODD).23 Into H358ON cells, HIF1αdPA or HIF1αΔODD was cotransfected with the Linear Hygromycin Marker (Clontech). After selection with hygromycin, single clones were isolated.19 This study was approved by the Nagoya University Center for Gene Research (Approval #14‐106).
+ Open protocol
+ Expand
3

Generation and Validation of Lrg1 Mouse Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lrg1−/− mouse strain in C57BL/6J background was obtained from the Knock-Out Mouse Project (KOMP) Repository (www.komp.org; #VG10067). Genotyping was performed as described previously 16 (link). For inducible LRG1 transgenic mice, the full-length mLrg1 ORF (NM_029796.2) with C-terminal V5 tag was subcloned into pTRE-tight vector (Takara Bio, Mountain View, CA). The sequence and orientation of the TRE-Tight-Lrg1-V5 insert were confirmed by restriction endonuclease and DNA sequencing. The DNA fragment encoding TRE-Tight-Lrg1-V5 was used for microinjection to generate the TRE-LRG1 transgenic mice in the FVB/NJ background. TRE-LRG1 mice were crossed with Pax8-rtTA mice (in FVB/NJ) to generate Pax8-rtTA;TRE-mLrg1 mice. Tubular overexpression of LRG1 was validated by quantitative PCR and western blot analysis of kidney cortices after 3 weeks of doxycycline-supplemented chow feeding (625mg/kg, Envigo). For the induction of LRG1 overexpression for fibrosis models, mice were given doxycycline-supplemented chow 1 week before UUO surgery or AAN injection and for the experimental duration. Phenotypes of Pax8-rtTA;TRE-mLrg1 mice without doxycycline induction and control littermates expressing either Pax8-rtTA or TRE-mLrg1 transgene with doxycycline induction were indistinguishable from normal mouse kidneys and used interchangeably as wildtype (WT) controls.
+ Open protocol
+ Expand
4

Generating Doxycycline-Inducible TopBP1 Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Previously cloned (14 (link)) human full-length TopBP1 coding sequence (CDS, Uniprot Q92547) was ligated into pEGFP-C1 mammalian expression vector (BD Biosciences, Genbank #U55763). Mutated TopBP1 in pEGFP-C1 was generated by introducing a tryptophan (W) to arginine (R) mutation at amino acid 1145 of TopBP1 using overlap extension polymerase chain reaction (PCR). For the preparation of stable Tet-On Advanced cell lines, the whole CDS of eGFP-TopBP1 WT or eGFP-TopBP1 W1145R was ligated to the pTRE-Tight vector (Clontech). TopBP1 deletion mutants were prepared and ligated into pEGFP-C1 vector using In-Fusion HD EcoDry Cloning Kit (Clontech). The correct sequences of all constructs were verified by sequencing (ABI Prism 310 Genetic Analyzer). DNA transfections were done with Effectene (Qiagen) transfection reagent.
Stable doxycycline-inducible U2OS cell lines were generated using Tet-On Advanced gene expression system (Clontech). Cells were designed to express either wild-type (WT) or W1145R mutant of human TopBP1 N-terminally fused to Enhanced Green Fluorescent Protein (eGFP).
+ Open protocol
+ Expand
5

Assessing Uridylated pre-let-7 Stability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Northern blot analysis was carried out as previously described.22 (link),23 (link) γ32P-ATP-labeled oligonucleotides complementary to miRNAs were used as probes. U6 snRNA was used as a control for quantification. The stability of uridylated pre-let-7 was assessed using the Tet-Off Advanced Inducible Gene Expression System (Clontech). pTRE-Tight-pri-let-7g was constructed by inserting pri-let-7g into pTRE-Tight vector (Clontech). HepG2 cells with pTet-off Advanced vector (Clontech) were transfected with pTRE-Tight–pri-let-7g and control siRNA or siRNA for MCPIP1. At 48 h post-transfection, pri-let-7g transcription was halted by addition of doxycycline (DOX) (1 μg/mL). Total RNA was extracted at the indicated time periods and subjected to northern blot analysis.
+ Open protocol
+ Expand
6

Inducible TAZ4SA Transgenic Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human-TAZ4SA was cloned into the pTRE-Tight vector (Clontech, CA). Pronuclear injection of linearized pTRE-TAZ4SA transgene was performed at the Targeting and Transgenic Core Facility of RPCI. The pTRE-TAZ4SA transgenic mice were genotyped by a PCR primer set (in the 5′ to 3′ direction) - Forward primer: GCTCGTTTAGTGAACCGT and Reverse primer: TGTGGTGATTTTTTCTATGTG. The pTRE-TAZ4SA transgenic mice were maintained in a C57BL6 background. The MMTV-rtTA strain (B6; SJL-Tg (MMTV-rtTA)4-1 Jek/J) was purchased from The Jackson Laboratory29 (link). The MMTV-rtTA transgenic mice were genotyped by a PCR primer set (5′ to 3′) - Forward primer: CTGGTCATCATCCTGCCTTT and Reverse primer: GGCGAGTTTACGGGTTGTTA. For TAZ4SA induction, transgenic and non-transgenic littermates were fed with Doxycycline-containing chow (200 mg/kg; Bioserve, NJ). The care and use of animals were performed under the rules provided by the Declaration of Helsinki and approved by the Institutional Animal Care and Use Committee of the Roswell Park Cancer Institute (Buffalo, NY).
+ Open protocol
+ Expand
7

Versatile Genetic Regulation Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols

pK036 (pTRE-Flpe-WPRE): To generate the pK036 vector, the coding sequences of Flpe was amplified from pK016.pCAG-Flpe-ires-Puro (GeneBridge) using the primer pair AY101/AY102. The resulting product was ligated into BamHI/NotI sites of the pK026 [pTRE-Tight vector (Clontech)]. WPRE, excised with NotI from pK029 vector, was ligated into NotI site of obtained TRE-Flpe vector.

pK037 (pCAG-FRT-stop-FRT-RFP-ires-tTA-WPRE): pK037 vector was generated by replacing loxP-stop-loxP sequence with the FRT-stop-FRT sequence between EcoRI/SalI sites of pK029. FRT-stop-FRT sequence was amplified from the pBS302 vector (Gibco-BRL) using the primer set HM009/HM008.

pK068 (pCAG-FRT-stop-FRT-EGFP-ires-tTA-WPRE): For the pK068 vector, EGFP-ires-tTA sequence was excised with SalI and NotI from pK038 vector and cloned into SalI /NotI sites of pK037 vector. WPRE, excised with NotI from pK029, was ligated into NotI sites of obtained vector.

+ Open protocol
+ Expand
8

Cloning H-Ras Gene into pTRE-Tight Vector

Check if the same lab product or an alternative is used in the 5 most similar protocols
pCDNA3.1+ human H-Ras S17 3xHA (N-terminus) plasmid was purchased from the UMR cDNA Resource Center (University of Missouri-Rolla, Rolla, Missouri). The plasmid was cut with HindIII and XbaI to remove the Ras insert. pTRE-Tight vector was purchased from CLONTECH Laboratories Inc. and cut with HindIII, XbaI, and then calf intestinal alkaline phosphatase (Fisher Scientific). The insert and vector were ligated (3:1 ratio) and products were sequenced to confirm insertion.
+ Open protocol
+ Expand
9

Regnase-1 Expression Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Regnase-1 expression vectors, including pFLAG-CMV2 (Sigma) and pcDNA3.1-Myc, and viral expression vectors, such as pMRX-FLAG-Regnase-1-ires-puro, have previously been described (Matsushita et al., 2009 (link); Iwasaki et al., 2011 (link)). Truncated versions of Regnase-1 lacking the N or C terminus were constructed by PCR amplification of Regnase-1 cDNA, which was inserted into the pFLAG-CMV2 vector. Point mutations of Regnase-1 expression constructs were prepared by using the Quickchange II Site-Directed Mutagenesis Kit (Agilent Technologies). For overexpression in Escherichia coli, the portion of Regnase-1 containing the proline-rich domain and C-terminal domain (441–598) was amplified from Regnase-1 cDNA and inserted into the pGEX-6P vector (GE Healthcare). Myc-Act1, human influenza hemagglutinin epitope (HA)-TBK1, and HA-IKKi were PCR amplified from each cDNA and inserted in-frame into a pcDNA3.1 vector. The pTRE-tight-IL-6-CDS+3′-UTR vector has previously been described (Matsushita et al., 2009 (link)). The IκBζ-CDS + 3′UTR (315–3815) was PCR amplified from its cDNA and inserted in-frame into a pTRE-tight vector (Clontech).
+ Open protocol
+ Expand
10

Inducible Expression of Mouse ZBED6

Check if the same lab product or an alternative is used in the 5 most similar protocols
The coding sequence of mouse ZBED6 was cloned directly downstream of Tetracycline-responsive promoter in pTRE-Tight vector (Clontech) between BamHI and SalI sites. The EndoFree Plasmid Maxi kit (Qiagen) was used to produce endotoxin-free pTRE-ZB construct. In the same time, Tet-On-Advanced vector (Clontech) was used to generate stable C2C12 cell line expressing Tet-controlled transactivator protein. Those stable cells were transit transfected with pTRE-ZB construct (1 μg/ml) using lipofectamin2000 (Invitrogen). Doxycycline (500 ng/ml) was added to the culture medium to induce the expression of ZBED6 from pTRE-ZB vector.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!